Current Appointments & Affiliations
Professor of Medicine
·
2024 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021.
Journal Article NPJ Breast Cancer · November 13, 2025 Tumor biologic risk has replaced anatomic disease burden for guiding chemotherapy use in HR-positive, early-stage breast cancer. Recent surgical trials support less frequent axillary lymph node dissection, potentially impacting incidence of N2-3 diagnoses. ... Full text Link to item Cite"Silent Spring" revisited: Implications for breast cancer care.
Journal Article Breast · November 11, 2025 Full text Link to item CiteMulti-receptor targeted therapy of breast cancer and brain metastases with a novel QUAD-drug conjugate.
Journal Article Breast Cancer Res · October 27, 2025 BACKGROUND: Identifying treatments for triple-negative breast cancer (TNBC) remains a critical medical need. We have found that Interleukin 13 receptor alpha 2 (IL-13RA2), EphA2, EphA3 and EphB2 receptors are over-expressed collectively in majority of pati ... Full text Link to item CiteRecent Grants
A Pragmatic Phase II Trial of Chemotherapy +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Clinical TrialPrincipal Investigator · Awarded by Indiana University · 2025 - 2030I-SPY 2 Trial: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Clinical TrialPrincipal Investigator · Awarded by Quantum Leap Healthcare Collaborative · 2025 - 2030A single shot therapy will accelerate the elimination of breast cancer
ResearchResearch Professional · Awarded by United States Army Medical Research Acquisition Activity · 2024 - 2028View All Grants
Education, Training & Certifications
Johns Hopkins University, School of Medicine ·
1995
M.D.